The ERP Biomarker Qualification Consortium, LLC

DUBLIN--( BUSINESS WIRE )--The "Analytical Method Validation, Verification and Transfer" training has been added to ResearchAndMarkets.com's offering. Reliable analytical results are necessary to make informed decision about the quality and safety of the products in the pharmaceutical industry. In addition, such analytical data are required for regulatory submissions in support of the drug product registrations. Therefore, meaningful experimental designs including system suitability parameters must be planned for the intended use of the procedure. In this course, general guideline for the determination of the analytical characteristics for different types of validation procedures is highlighted for the analysis of both the drug substance and drug product. The factors to consider for verification of the compendial procedures will also be discussed. In addition, different approaches for the transfer of analytical procedure from one lab (transferring) to other lab(s) (receiving) under different circumstances will be covered. Other related topics for obtaining reliable data will also be discussed. These topics include analytical instrument qualification as well as how to set, handle and monitor specifications. Due to global nature of pharmaceutical industry, other quality topics on both regulatory (ICH) and compendial (USP) harmonization are also covered. These topics are valuable for scientists directly or indirectly involved with the drug development, analysis. stability studies or regulatory/compendial submissions. Learning Objectives Drug Approval Process and Regulatory Requirements (private standards) Pharmacopeias and Compendial Approval Process (public standards) Compendial Harmonization Process Chromatography System Suitability Requirements Allowed Adjustments of Chromatographic System Parameters Analytical Instrument Qualifications including DQ, IQ, OQ, PQ Analytical Method Validation Analytical Method Verification Analytical Method Transfer Alternative to Official procedure and options Analytical Procedure Life Cycle How to Set Specifications and how to handle out-of-specification (OOS) and out-of-trend (OOT) results Who Should Attend: Contract Laboratories (CRO) Academia (pharmacy, Pharmaceutical Industry, Pharmaceutical, Chemistry) Government (FDA or regulatory authorities) Quality Analysis Managers and Personnel Controlling Personnel Analytical and or Formulation Chemists Quality Control Managers and Personnel Lab Supervisors and Managers Compendial Liaisons Senior or Graduate students (chemistry, pharmaceutical, pharmacy) Pharmaceutical scientists/Pharmacists working in Industry Key Topics Covered: DAY 01 Seminar objectives review, expectations, and scope. Drug Approval Process and Regulatory (FDA) Requirements (private standards) Pharmacopeias and Compendial (USP) Approval Process (public standards) Compendial Harmonization Process Chromatography System Suitability Requirements Allowed Adjustments of Chromatographic System Parameters Analytical Instrument Qualifications Instrument Categories Qualification Phases (DQ, IQ, OQ, PQ) Analytical Method Validation (typical validation parameters) Specificity Precision/Accuracy Linearity/Range LOD and LOQ Analytical Method Verification FDA and USP Requirements Factors to Consider Analytical Method Transfer Different Approaches Summary and Review DAY 02 Investigative Procedure Life Cycle Setting Specifications FDA regulations and ICH guidelines (Q6A) Out-of-Specification (OOS) Out of Trend (OOT) How to handle OOS and OOT? Summary and Review For more information about this training visit https://www.researchandmarkets.com/r/lf88xx

SHANGHAI, Nov. 3, 2022 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced that one of the China operating entities of which the Company consolidates the financial results with through certain contractual arrangements, Chongqing Xinjiang Pharmaceutical Co., Ltd. ("Xinjiang Pharmaceutical") has obtained a series of pharmaceutical related licenses, which lay a solid foundation for Zhongchao to develop pharmaceutical services and expand to the pharmaceutical market. The Company believes that the operation of Xinjiang Pharmaceutical will further strengthen the upgraded "Medical-Pharmaceutical-Patient" model. Since the beginning of 2022, embracing the development opportunity of a series of investment promotion of pharmaceutical industry initiated by the Chongqing government, Xinjiang Pharmaceutical has been able to develop rapidly. Xinjiang Pharmaceutical has obtained Pharmaceutical Trade License, Medical Device Trade License, Qualification Certificate for Drug Information Service over the Internet and other related licenses. Xinjiang Pharmaceutical plans to engage in pharmaceutical import and export trade, OME (original equipment manufacturer) production, medical consumables operation, and pharmaceutical internet services, aiming to continuously expand the industry chain and supply chain of the pharmaceutical market in China. Meanwhile, it remains committed to becoming a competitive technology-based pharmaceutical service enterprise. Weiguang Yang, Chairman and Chief Executive Officer of Zhongchao, commented, "The rapid development of Xinjiang Pharmaceutical will further promote our strategy of providing pharmaceutical services for patients with oncology or other major diseases. Over the past ten years, Zhongchao has accumulated abundant resources of medical education and platform and established long-term and stable strategic partnerships with many domestic and foreign pharmaceutical companies. We intend to integrate the high-quality resources we own to create a pharmaceutical services system covering the whole industry chain. We aim to not only improve the drug accessibility and affordability for patients but bring in greater social economic benefits." About Zhongchao Inc. Zhongchao Inc. is an offshore holding company incorporated in the Cayman Islands. It conducts operations in China through the contractual arrangements between its wholly owned subsidiary and PRC operating entities. Zhongchao Inc. is a platform-based internet technology company offering services to patients with oncology and other major diseases. The PRC operating entities provide online healthcare information, professional training and educational services to healthcare professionals under their "MDMOOC" platform ( ), offer patient management services in the professional field of tumor and rare diseases through Zhongxin, offer internet healthcare services through Zhixun Internet Hospital, and pharmaceutical services through Xinjiang Medical and operate an online information platform, Sunshine Health Forums, to general public. More information about the Company can be found at its investor relations website at . Safe Harbor Statement This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the growth of the professional training and educational services market in China and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC, the length and severity of the recent coronavirus outbreak, including its impacts across our business and operations. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at . The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof. For more information, please contact: At the Company: Pei Xu, CFO Email: xupei@mdmooc.org Phone: +86 21-3220-5987 Investor Relations: Sherry Zheng Weitian Group LLC Email: shunyu.zheng@weitian-ir.com Phone: +1 718-213-7386 Company Codes: NASDAQ-NMS:ZCMD

DIGITAL ACCESS TO THE WORLD CREATES A BETTER FUTURE EINDHOVEN, Netherlands, Sept. 28, 2022 /PRNewswire/ -- China （Shenzhen）Innovation and Entrepreneurship Competition, known as the "Olympics" of innovation and entrepreneurship circle, is here again! The sixth International competition was officially launched on July 15, 2022, in the form of "online + offline" integration, covering 10 countries. IEC Technology Industry (Shenzhen) Co., Ltd. is the co-organizer (with government) of this event. At the same time, for the landing development enterprises who meet the conditions will be eligible to receive up to 1 million yuan start-up subsidies, individual can receive up to 1.85 million yuan bonus and start-up subsidies. The competition will also provide industrial support, science and technology finance, project incubation and other support for high-quality entrepreneurial projects, and give full play to the "four-chain" synergies of industrial chain, innovation chain, talent chain and education chain to help build the Shenzhen Guangdong-Hong Kong-Macao Greater Bay Area and the pilot demonstration zone. Highlights of the Competition Insight into the latest trends in global technology, focusing on seven industry tracks, such as "the New Generation of Electronic Information, Digital and Fashion, High-end Equipment Manufacturing, Green and Low-carbon, New Materials, Biomedicine and Health, Marine Economy" Explore cutting-edge technology application scenarios, both "Industrial Software Design" and "Semiconductor Technology Research and Development" A "cloud event" comes together, spanning space, and connects 10 divisions around the world The rewards are generous, with eligible businesses eligible for up to ¥1 million in subsidies, and individuals up to ¥1.85 million There are many well-known venture capital institutions, for nearly 100 well-known venture capital institutions, all participating projects can get social capital investment opportunities through the investment docking service platform of the competition A comprehensive landing service system, covering "entrepreneurship counseling, mentors-experts docking, support policy docking" and so on, facilitates the rapid development of high-quality projects Introduction to the Competition The China (Shenzhen) Innovation & Entrepreneurship International Competition aims to further promote the organic combination of talent, technology and capital, attract more overseas talents to start business and work in Shenzhen, select overseas high-end projects to settle in Shenzhen, and promote Shenzhen to become an international and innovative city full of charm, energy, vibrancy and creativity. The Competition is divided into six stages: signing up, overseas competitions at divisions, reward competition, industrial final, the final and award ceremony. The total prize for the Competition is RMB 8.75 million, which is divided into four parts: final prize, industrial final prize, reward final prize and overseas division prize. Meanwhile, the Competition will also set up a competition service platform and provide services for projects taking part in the Competition through establishing the competition service institutions, the expert pool and the venture capital pool in cooperation with investment institutions and provide a series of supporting policies in entrepreneurial space, business services, talent policy and other aspects. Overseas Division London, U.K. Division Berlin, Germany Division Sydney, Australia Division Toronto, Canada Division Tokyo, Japan Division Tel Aviv, Israel Division Eindhoven, Netherlands Division Madrid, Spain Division Silicon Valley, U.S. Division Paris, France Division Competition schedule Sign up: To end on September 30 Overseas Division Competition: Early October - Early November Reward Competition: Early November Industry Final: Mid November - Late December Final and Awarding: Late December (Note: The specific time of each competition is subject to notices by the Organizing Committee of International Competition) Qualification requirements Overseas high-level entrepreneurial teams or individuals with innovative achievements and entrepreneurial plans. The participant doesn't register or act as legal representatives or shareholders of commercial entities in Shenzhen but plans to set up enterprises in Shenzhen or reach cooperation with relevant industries in Shenzhen after the competition. The ownership of products, technologies or related patents of the projects shall belong to the participants. All participants shall confirm that there is no property right dispute with others, and shall be responsible for any liabilities arising from/relating to infringement. Participants and projects that have won awards in the 1st China (Shenzhen) Innovation Competition of International Talent and previous China (Shenzhen) Innovation &Entrepreneurship Competition (including domestic and international competitions) cannot participate in this competition repeatedly. How to Signing Up Please visit for signing up About Longhua District, Shenzhen Longhua District was officially established as an administrative district on January 7, 2017. After years of development and planning, it has become a vibrant and promising hot spot for entrepreneurship. Longhua District takes the Digital Longhua and the Urban Core as its strategic goals, adheres to the concepts of digital industrialization, industrial digitization, governance digitization and digital value, strives to build a Digital Longhua consisting of digital economy, digital urban area and digital governance and establishes the regional development pattern of "one digital economic circle, one central dynamic area and three major urban corridors". About Eindhoven, The Netherlands Eindhoven, the fourth largest industrial city in the Netherlands, is a city full of innovation and one of the four major high-tech settlements in Europe. It has established close ties with many outstanding companies such as Philips and DSM, and attaches great importance to modern information and communication technology. High Tech Campus The High Tech Campus Eindhoven used to be the location of the research and development headquarters of the Philips Group in the Netherlands. In 2015, it was named the Smartest Park in the world by Forbes. The park covers an area of 1 square kilometer and consists of three parts. Among them, the International Residential Community in the northeast is driven by the Eindhoven University of Technology and supporting international schools; the Design Industry Cluster in the northwest surrounds the Strijp S creative industry zone; and the High Tech Campus built Philips in south is a research and development base for various high-tech products. The park focuses on the development of three leading industries: health, energy and intelligent environment, centering on five major fields of microsystems, embedded systems, medical technology, infotainment systems and big data. Connect with Us Company: Outpie Partners B.V.; IEC Technology Industry (Shenzhen) Co., Ltd. Contact Person: Xiaomeng Li, Lin Guopeng Email: [email protected]; [email protected] Website: Telephone: 31-645535526, 86-18344256123 Address: High Tech Campus 9, 5656AE Eindhoven, the Netherlands;Tusincere Park, Longgang District, Shenzhen, China SOURCE IEC Technology Industry (Shenzhen) Co., Ltd.